Loading insider details...
Latest Form 4 (Aug 21, 2026): Exercise/Conversion of 67,741 NMRA shares, $48.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Neumora Therapeutics, Inc. (NMRA) | Exercise/Conversion | 67,741 | $48.8K |
| Aug 19, 2026 | Neumora Therapeutics, Inc. (NMRA) | Exercise/Conversion | 40,890 | $29.4K |
| Feb 19, 2026 | Neumora Therapeutics, Inc. (NMRA) | Sale | 6,165 | $21.9K |
| Jan 9, 2026 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 750,000 | n/a |
| Nov 13, 2025 | Neumora Therapeutics, Inc. (NMRA) | Sale | 114,703 | $307.0K |
| May 30, 2025 | Neumora Therapeutics, Inc. (NMRA) | Disposition to Issuer | 40,890 | n/a |
| Feb 20, 2025 | Neumora Therapeutics, Inc. (NMRA) | Sale | 8,565 | $14.3K |
| Feb 18, 2025 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 1,000,000 | n/a |
| Sep 13, 2024 | Neumora Therapeutics, Inc. (NMRA) | Gift | 137,538 | n/a |
| Apr 24, 2024 | Neumora Therapeutics, Inc. (NMRA) | Gift | 114,703 | n/a |